present
Inflammatix is developing an innovative point-of-care instrument platform to be used with a test to aid in the diagnosis of acute infection and sepsis by harnessing the immune system to deliver advanced immune response diagnostics. Our test rapidly informs the clinician about the likelihood of bacterial or viral infection and the need for ICU level care in the emergency department. Faster results may translate into more timely and appropriate therapy and level of care decisions. *Products in development, are not for sale, and do not have marketing approval or clearance from regulatory authorities in any jurisdiction.
- Driving technological innovation and spearheading innovation for enhanced system performance.
- Revolutionized divisions to achieve new heights and reach exceptional results through strategic planning and effective collaboration.
- Driving digital transformation initiatives to redefine the company's position as a leader in the industry.
- Building a successful startup from the ground up, revolutionizing the industry through strategic business partnerships.
- Driving technological innovation, novating market, and cutting-edge industries through strategic planning and implementation.
- Building a strong and inclusive governance structure to deliver effective governance principles.